J. Goldman & CO LP Foghorn Therapeutics Inc. Transaction History

J. Goldman & CO LP

  • $3.27 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$8.48 - $16.84 $216,138 - $429,217
-25,488 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$8.87 - $22.1 $59,872 - $149,175
6,750 Added 36.02%
25,488 $388,000
Q4 2021

Feb 14, 2022
SELL
$10.79 - $22.87 $526,141 - $1.12 Million
-48,762 Reduced 72.24%
18,738 $429,000
Q3 2021

Nov 15, 2021
BUY
$8.33 - $15.02 $562,275 - $1.01 Million
67,500 New
67,500 $940,000

Others Institutions Holding FHTX

# of Institutions
72
Shares Held
32.7M
Call Options Held
6K
Put Options Held
1.8K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email